| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |